Company news
bonyf NV news in 2025
bonyf NV's news releases, calls and decks from 2025, newest first.
Company Update on Market Trading Dynamics and Business Fundamentals
December 22, 2025
bonyf: PerioCream becomes the most in-demand bonyf innovation
November 24, 2025
Bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
October 15, 2025
Bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf
September 15, 2025
Bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
September 5, 2025
Periocream: The Future Commercial Winner for bonyf
August 11, 2025
Bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
July 14, 2025
Annual Results 2024
June 30, 2025
Bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India
June 3, 2025
Bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
May 15, 2025
Bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
May 15, 2025
Bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
April 8, 2025
Bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
March 13, 2025
Bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy
February 18, 2025
Bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
January 30, 2025